MicroRNA-218-5p-Ddx41 axis restrains microglia-mediated neuroinflammation through downregulating type I interferon response in a mouse model of Parkinson's disease
- PMID: 38229084
- PMCID: PMC10792813
- DOI: 10.1186/s12967-024-04881-w
MicroRNA-218-5p-Ddx41 axis restrains microglia-mediated neuroinflammation through downregulating type I interferon response in a mouse model of Parkinson's disease
Abstract
Background: Parkinson's disease (PD) is a neurodegenerative disorder characterized by the loss of dopaminergic (DA) neurons in the substantia nigra (SN). Microglia-mediated neuroinflammation has been largely considered one of main factors to the PD pathology. MicroRNA-218-5p (miR-218-5p) is a microRNA that plays a role in neurodevelopment and function, while its potential function in PD and neuroinflammation remains unclear.
Methods: We explore the involvement of miR-218-5p in the PD in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse model. The miR-218-5p agomir used for overexpression was delivered into the substantia nigra (SN) by bilateral stereotaxic infusions. The loss of dopaminergic (DA) neurons and microglial inflammation in the SN was determined using Western blotting and immunofluorescence. Motor function was assessed using the rotarod test. RNA sequencing (RNA-seq) was performed to explore the pathways regulated by miR-218-5p. The target genes of miR-218-5p were predicted using TargetScan and confirmed using dual luciferase reporter assays. The effects of miR-218-5p on microglial inflammation and related pathways were verified in murine microglia-like BV2 cells. To stimulate BV2 cells, SH-SY5Y cells were treated with 1-methyl-4-phenylpyridinium (MPP+) and the conditioned media (CM) were collected.
Results: MiR-218-5p expression was reduced in both the SN of MPTP-induced mice and MPP+-treated BV2 cells. MiR-218-5p overexpression significantly alleviated MPTP-induced microglial inflammation, loss of DA neurons, and motor dysfunction. RNA sequence and gene set enrichment analysis showed that type I interferon (IFN-I) pathways were upregulated in MPTP-induced mice, while this upregulation was reversed by miR-218-5p overexpression. A luciferase reporter assay verified that Ddx41 was a target gene of miR-218-5p. In vitro, miR-218-5p overexpression or Ddx41 knockdown inhibited the IFN-I response and expression of inflammatory cytokines in BV2 cells stimulated with MPP+-CM.
Conclusions: MiR-218-5p suppresses microglia-mediated neuroinflammation and preserves DA neurons via Ddx41/IFN-I. Hence, miR-218-5p-Ddx41 is a promising therapeutic target for PD.
Keywords: DEAD-box helicase 41; Interferon; Microglia; Neuroinflammation; Parkinson’s disease; miR-218-5p.
© 2024. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures







Similar articles
-
Regulatory mechanism of miR-20a-5p in neuronal damage and inflammation in lipopolysaccharide-induced BV2 cells and MPTP-HCl-induced Parkinson's disease mice.Psychogeriatrics. 2024 Jul;24(4):752-764. doi: 10.1111/psyg.13109. Epub 2024 Apr 25. Psychogeriatrics. 2024. PMID: 38664198
-
MicroRNA-124 regulates the expression of p62/p38 and promotes autophagy in the inflammatory pathogenesis of Parkinson's disease.FASEB J. 2019 Jul;33(7):8648-8665. doi: 10.1096/fj.201900363R. Epub 2019 Apr 17. FASEB J. 2019. PMID: 30995872
-
MicroRNA-190 alleviates neuronal damage and inhibits neuroinflammation via Nlrp3 in MPTP-induced Parkinson's disease mouse model.J Cell Physiol. 2019 Dec;234(12):23379-23387. doi: 10.1002/jcp.28907. Epub 2019 Jun 24. J Cell Physiol. 2019. PMID: 31232472
-
Calpain activation and progression of inflammatory cycles in Parkinson's disease.Front Biosci (Landmark Ed). 2022 Jan 13;27(1):20. doi: 10.31083/j.fbl2701020. Front Biosci (Landmark Ed). 2022. PMID: 35090325 Free PMC article. Review.
-
Regulatory Non-coding RNAs Involved in Oxidative Stress and Neuroinflammation: An Intriguing Crosstalk in Parkinson's Disease.Curr Med Chem. 2024;31(34):5576-5597. doi: 10.2174/0929867331666230817102135. Curr Med Chem. 2024. PMID: 37592769 Review.
Cited by
-
Neuroinflammation in Parkinson's disease: focus on the relationship between miRNAs and microglia.Front Cell Neurosci. 2024 Jul 26;18:1429977. doi: 10.3389/fncel.2024.1429977. eCollection 2024. Front Cell Neurosci. 2024. PMID: 39131043 Free PMC article. Review.
-
MicroRNAs in microglia: deciphering their role in neurodegenerative diseases.Front Cell Neurosci. 2024 May 15;18:1391537. doi: 10.3389/fncel.2024.1391537. eCollection 2024. Front Cell Neurosci. 2024. PMID: 38812793 Free PMC article. Review.
-
Identification of Downregulated MECR Gene in Parkinson's Disease Through Integrated Transcriptomic Analysis and Validation.Int J Mol Sci. 2025 Jan 10;26(2):550. doi: 10.3390/ijms26020550. Int J Mol Sci. 2025. PMID: 39859268 Free PMC article.
-
Elevated miRNA-21, miRNA-155, and miRNA-182 levels correlate with cytokine dysregulation in neurological disorders and indicate potential for biomarker and therapy development.Sci Rep. 2025 Jul 2;15(1):23523. doi: 10.1038/s41598-025-05372-8. Sci Rep. 2025. PMID: 40603418 Free PMC article.
-
An update on the involvement of inflammatory mediators in Parkinson's disease pathogenesis.Arch Toxicol. 2025 Sep;99(9):3527-3552. doi: 10.1007/s00204-025-04088-y. Epub 2025 Jun 3. Arch Toxicol. 2025. PMID: 40461681 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical